Word

RED CELL THERAPEUTICS

Status

Registered

Status Code

700

Status Date

Tuesday, October 19, 2021

Serial Number

88807844

Registration Number

6532454

Registration Date

Tuesday, October 19, 2021

Mark Type

4000

Filing Date

Monday, February 24, 2020

Trademark Owner History

Rubius Therapeutics, Inc. - Original Registrant

Classifications

5 Cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; none of the foregoing used as vitamin-mineral supplements or for animals

"CELL THERAPEUTICS"

Trademark Events

Oct 19, 2021

Registered-Supplemental Register

Sep 15, 2021

Law Office Publication Review Completed

Sep 7, 2021

Approved For Registration Supplemental Register

Sep 7, 2021

Examiner's Amendment Entered

Sep 7, 2021

Notification Of Examiners Amendment E-Mailed

Sep 7, 2021

Examiners Amendment E-Mailed

Sep 7, 2021

Examiners Amendment -Written

Jul 21, 2021

Teas/Email Correspondence Entered

Jul 20, 2021

Correspondence Received In Law Office

Jul 20, 2021

Teas Response To Office Action Received

Feb 9, 2021

Notice Of Acceptance Of Amendment To Allege Use E-Mailed

Feb 6, 2021

Notification Of Non-Final Action E-Mailed

Feb 6, 2021

Non-Final Action E-Mailed

Feb 6, 2021

Non-Final Action Written

Feb 6, 2021

Use Amendment Accepted

Jan 12, 2021

Amendment To Use Processing Complete

Nov 19, 2020

Use Amendment Filed

Nov 20, 2020

Teas/Email Correspondence Entered

Nov 19, 2020

Correspondence Received In Law Office

Nov 19, 2020

Teas Response To Office Action Received

Nov 19, 2020

Teas Amendment Of Use Received

May 20, 2020

Notification Of Non-Final Action E-Mailed

May 20, 2020

Non-Final Action E-Mailed

May 20, 2020

Non-Final Action Written

May 13, 2020

Assigned To Examiner

Mar 21, 2020

Preliminary/Voluntary Amendment - Entered

Mar 13, 2020

Assigned To Lie

Mar 6, 2020

Teas Voluntary Amendment Received

Feb 27, 2020

New Application Office Supplied Data Entered In Tram

Feb 27, 2020

New Application Entered In Tram